Etoposide combined with cytarabine and pegfilgrastim for poorly mobilizing patients with multiple myeloma and lymphoma: A prospective multicentre study

Documenti analoghi

• Venetoclax plus daunorubicin and cytarabine in newly diagnosed acute myeloid leukemia patients: A propensity score‐matched analysis
  di: Rong Wang, et al.
  Pubblicazione: (2024)
• Predictive model of the efficiency of hematopoietic stem cell collection in patients with multiple myeloma and lymphoma based on multiple peripheral blood markers
  di: Longrong Ran, et al.
  Pubblicazione: (2024)
• Lomustine, Etoposide and Cyclophosphamide as Conditioning for Auto‐HCT in Lymphomas
  di: Rafaella Cabral Samico, et al.
  Pubblicazione: (2025)
• Successful treatment pure red cell aplasia after ABO major mismatched allogeneic hematopoietic stem cell transplantation with avatrombopag and low dose rituximab
  di: Junjie Cao, et al.
  Pubblicazione: (2024)
• Docetaxel, cisplatin, and fluorouracil with pegfilgrastim on day 3 as neoadjuvant chemotherapy for esophageal cancer
  di: Osamu Maeda, et al.
  Pubblicazione: (2024)